Montrusco Bolton Investments Inc. Sells 51,173 Shares of Varian Medical Systems, Inc. (VAR)

Montrusco Bolton Investments Inc. decreased its holdings in shares of Varian Medical Systems, Inc. (NYSE:VAR) by 49.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 53,026 shares of the medical equipment provider’s stock after selling 51,173 shares during the quarter. Montrusco Bolton Investments Inc. owned approximately 0.06% of Varian Medical Systems worth $5,882,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in VAR. Pensionfund Sabic bought a new stake in Varian Medical Systems in the 4th quarter valued at $1,556,000. Pensionfund DSM Netherlands bought a new stake in Varian Medical Systems in the 4th quarter valued at $3,001,000. Parametric Portfolio Associates LLC boosted its holdings in Varian Medical Systems by 4.2% in the 3rd quarter. Parametric Portfolio Associates LLC now owns 631,098 shares of the medical equipment provider’s stock valued at $63,148,000 after purchasing an additional 25,238 shares during the period. GSA Capital Partners LLP boosted its holdings in Varian Medical Systems by 21.2% in the 3rd quarter. GSA Capital Partners LLP now owns 13,145 shares of the medical equipment provider’s stock valued at $1,315,000 after purchasing an additional 2,303 shares during the period. Finally, Americafirst Capital Management LLC bought a new stake in Varian Medical Systems in the 3rd quarter valued at $665,000.

Shares of Varian Medical Systems, Inc. (NYSE VAR) traded up $0.25 during midday trading on Friday, hitting $109.57. 545,800 shares of the stock traded hands, compared to its average volume of 764,092. The company has a market cap of $10,070.00, a price-to-earnings ratio of 39.70, a PEG ratio of 3.32 and a beta of 0.68. Varian Medical Systems, Inc. has a one year low of $76.94 and a one year high of $114.09.

Varian Medical Systems (NYSE:VAR) last released its quarterly earnings data on Wednesday, October 25th. The medical equipment provider reported $1.09 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.10). Varian Medical Systems had a return on equity of 23.68% and a net margin of 8.85%. The firm had revenue of $739.00 million for the quarter, compared to the consensus estimate of $741.69 million. During the same period in the previous year, the business earned $1.03 EPS. The firm’s revenue was down 1.1% compared to the same quarter last year. analysts predict that Varian Medical Systems, Inc. will post 4.11 earnings per share for the current fiscal year.

In other Varian Medical Systems news, SVP John W. Kuo sold 7,991 shares of Varian Medical Systems stock in a transaction that occurred on Monday, January 8th. The shares were sold at an average price of $110.65, for a total value of $884,204.15. Following the transaction, the senior vice president now owns 27,363 shares of the company’s stock, valued at $3,027,715.95. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Timothy E. Guertin sold 10,000 shares of Varian Medical Systems stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $111.46, for a total transaction of $1,114,600.00. Following the completion of the transaction, the director now directly owns 2,161 shares in the company, valued at approximately $240,865.06. The disclosure for this sale can be found here. Insiders have sold a total of 113,681 shares of company stock worth $12,607,207 in the last three months. 0.78% of the stock is owned by insiders.

A number of equities analysts have recently issued reports on VAR shares. Zacks Investment Research cut shares of Varian Medical Systems from a “hold” rating to a “sell” rating in a research note on Friday, October 27th. Citigroup increased their price objective on shares of Varian Medical Systems from $119.00 to $121.00 and gave the company a “neutral” rating in a research note on Monday, October 30th. Royal Bank of Canada set a $105.00 target price on shares of Varian Medical Systems and gave the stock a “hold” rating in a research report on Thursday, November 30th. BTIG Research reiterated a “hold” rating on shares of Varian Medical Systems in a research report on Sunday, October 29th. Finally, Evercore ISI assumed coverage on shares of Varian Medical Systems in a research report on Wednesday, January 3rd. They set an “underperform” rating and a $100.00 target price for the company. Three analysts have rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $100.44.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally reported by Week Herald and is the sole property of of Week Herald. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://weekherald.com/2018/01/19/montrusco-bolton-investments-inc-has-5-88-million-position-in-varian-medical-systems-inc-var.html.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply